Nursanté
ActiveNursanté has been active since 2017 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €214k and a net result of €16k. Equity is growing by ~25.8% per year across the filed fiscal years. Its solvency ranks better than 67% of 16377 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).
Checked score
Score 2025
83
/ 100
Excellent▼ -7 vs 2024
The score combines four axes. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability38▼-62
Solvency100▲+1
Growth52▼-26
Stability100
Bankruptcy probability, 12 months
0.1%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €18k at 30 days acceptable
Liquidity ample (current ratio 4.59 against 2.45 in 2024), and 21.2% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Six signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Sector 86
lower
← fewer bankruptcies
more bankruptcies →
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
78.8%
Return on assets
5.9%
Age of the figures
11 mo
neutral · Latest accounts filed on time
The financial year that closed on 30-09-2025 was due by 30-04-2026 and was filed on 30-04-2026, 0 days ahead of the deadline.
NBB · 8 filingsDeviation from the deadline
2025
on the day
2024
on the day
2023
on the day
2022
28 d late
2021
16 d late
2020
22 d late
2019
on the day
← before the deadline
after the deadline →
neutral · The next deadline is still running
The next financial year closes on 30-09-2026 and is due by 30-04-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
12-09-2026 today30-09-2026 close30-04-2027 deadline
Financials · fiscal year 2025, micro schema
Equity
€214k▼ 8.3%
2024 · €233k
2018: €14k
2019: €19k
2020: €59k
2021: €136k
2022: €177k
2023: €251k
2024: €233k
2018 → 2025
Total assets
€271k▼ 29.3%
2024 · €384k
2018: €58k
2019: €59k
2020: €130k
2021: €185k
2022: €238k
2023: €332k
2024: €384k
2018 → 2025
Net result
€16k▼ 76.0%
2024 · €67k
2018: €19k
2019: €29k
2020: €81k
2021: €147k
2022: €41k
2023: €105k
2024: €67k
2018 → 2025
Working capital
€206k▼ 5.8%
2024 · €219k
2018: €7k
2019: €7k
2020: €51k
2021: €126k
2022: €146k
2023: €227k
2024: €219k
2018 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20212022202320242025Trend
Equity€136k-€177k▲ 30.3%€251k▲ 42.3%€233k▼ 7.4%€214k▼ 8.3%
Operating result€148k-€124k▼ 16.1%€130k▲ 4.7%€97k▼ 24.9%€18k▼ 81.6%
Net result€147k-€41k▼ 72.1%€105k▲ 156%€67k▼ 36.2%€16k▼ 76.0%
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result has fallen two years in a row; 2025 is 82% below 2024 and is the lowest year so far.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €271k
Fixed assets
€7k▼ 47.6%
Current assets
€264k▼ 28.7%
Equity and liabilities €271k
Equity
€214k▼ 8.3%
Debt
€58k▼ 61.9%
The debt ratio falls from 39.3% to 21.2%: debt falls faster than equity shrinks.
Key figures and ratios
EBITDA
€28k▼
2024 · €108k
Cash flow
€26k▼
2024 · €77k
Solvency
78.8%▲
2024 · 60.7%
Current ratio
4.59▲
2024 · 2.45
Quick ratio
4.59▲
2024 · 2.45
Debt / equity
0.27▼
2024 · 0.65
ROE
7.5%▼
2024 · 28.8%
ROA
5.9%▼
2024 · 17.5%
Interest coverage
14.98▼
2024 · 403.59
Debt
€58k▼
2024 · €151k
Debt ≤ 1 year
€58k▼
2024 · €151k
Staff costs
€134k▼
2024 · €174k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet
Code20242025
Assets
Total assets20/58€384k€271k▼
Fixed assets21/28€14k€7k▼
Tangible fixed assets22/27€14k€7k▼
Furniture and vehicles24€14k€7k▼
Other tangible fixed assets26€364€154▼
Current assets29/58€370k€264k▼
Amounts receivable after more than one year29€236k€213k▼
Other amounts receivable291€236k€213k▼
Amounts receivable within one year40/41€6k€3k▼
Trade receivables40€6k€323▼
Other amounts receivable41-€3k
Cash at bank and in hand54/58€123k€43k▼
Deferred charges and accrued income490/1€5k€5k=
Equity and liabilities
Total equity and liabilities10/49€384k€271k▼
Equity10/15€233k€214k▼
Contributions10/11€20k€20k=
Profit (loss) carried forward14€212k€193k▼
Amounts payable17/49€151k€58k▼
Amounts payable within one year42/48€151k€58k▼
Trade debts44€10k€3k▼
Suppliers440/4€10k€3k▼
Taxes, remuneration and social security45€140k€31k▼
Taxes450/3€40k€23k▼
Remuneration and social security454/9€100k€8k▼
Other amounts payable47/48-€23k
Income statement
Code20242025
Remuneration, social security and pensions62€174k€134k▼
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€10k€10k▼
Other operating charges640/8€2k€1k▼
Gross operating margin9900€283k€163k▼
Operating profit (loss)9901€97k€18k▼
Financial income75/76B€45€57▲
Recurring financial income75€45€57▲
Financial charges65/66B€267€2k▲
Recurring financial charges65€267€2k▲
Profit (loss) for the period before taxes9903€97k€16k▼
Income taxes67/77€30k-
Profit (loss) for the period9904€67k€16k▼
Profit (loss) for the period to be appropriated9905€67k€16k▼
Appropriation of the result
Profit (loss) to be appropriated9906€298k€228k▼
Profit (loss) brought forward from the previous period14P€231k€212k▼
Profit to be distributed694/7€86k€35k▼
Return on contributions (dividend)694€86k€35k▼
The notes to these accounts (5 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
30-04
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema
2025
30-09
Financial
Weakest financial yearnet €16k ▼76%
Net result drops to €16k, the lowest in the series.
30-04
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema
2024
30-04
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema
2023
30-09
Financial
Equity above €200kEq €251k ▲42.3%
6 profitable years in a row build equity to €251k.
28-05
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema · 28 days late
2022
30-09
Financial
Equity above €150kEq €177k ▲30.3%
5 profitable years in a row build equity to €177k.
16-05
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema · 16 days late
2021
30-09
Financial
Highest result since 2018net €147k ▲81%
Operating result €148k, net result €147k, both a record.
30-09
Financial
Liquidity doublescurrent ratio 3.55
Current ratio from 1.75 to 3.55; short-term debt falls from €68k to €50k.
30-09
Financial
Equity above €100kEq €136k ▲130%
4 profitable years in a row build equity to €136k.
22-05
NBB filing
Annual accounts filed
fiscal year 2020 · micro schema · 22 days late
2020
30-04
NBB filing
Annual accounts filed
fiscal year 2019 · micro schema
2019
07-05
NBB filing
Annual accounts filed
fiscal year 2018 · micro schema · 7 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
2 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Brussel · 1 establishment unit since 2017
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Zoomlaan 171000 BrusselGround area
9,625 m²
Building footprint
442 m²
Volume, LiDAR
9,784 m³
Parcel 21822R0383/00S000, Brussels · tallest building 25.8 m, ±7 floors. Linked by address, not a title deed.
1 establishment unit
Nursanté
since 20172.264.494.197
1 parcel
Brussels
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 21822R0383/00S000 | Brussels | 9,625 m² | 1 · 442 m² | 25.8 m · 7 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
EVANS
BE 0550.686.123
Anderlecht · Eq €214k
GLOBAL VISIONNAIRE YR
BE 0782.709.727
Elsene · Eq €213k
De Pauw Nursing
BE 0677.903.009
Grimbergen · Eq €213k
ABDERAHMAN NURSING
BE 0759.473.277
Wavre · Eq €212k
MRY Solutions
BE 0787.828.258
Liège · Eq €215k
Of 5,966 companies in sector 86940 we hold annual accounts for 1,793. 1,329 are within a factor 10 of this equity.See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded18-04-2017
Fiscal year end30-09
Activities, NACEBEL
86906Human health activities
86940Nursing and midwifery
Sources
Crossroads Bank for EnterprisesNational Bank · 8 filingsAddress and cadastre registers
Data from official sources, last processed on 12-09-2026. Scores and ratios are computed by Checked and are not a credit decision.
Contact details
1 entryWebsite:www.infirmiere-nursante.be